Additionally, 15d-PGJ2 can induce the expression of 15-hydroxyprostaglandin dehydrogenase, which is involved in the inactivation of oncogenic prostaglandin 2, through ROS-mediated activation of ERK1/2 and, subsequently, Elk-1 in breast cancer cells [120]. The gene discussed is MAPK3; the disease is breast cancer.